Rifamide in acute cholecystitis and biliary surgery

Area of Science:

• Microbiology
• Pharmacology
• Surgical Infectious Diseases

Background:

• Biliary tract infections pose significant clinical challenges.
• Antibiotic penetration and efficacy in the biliary tract are critical.
• Rifamide is a potential therapeutic agent for biliary tract infections.

Purpose of the Study:

• To determine the in vitro susceptibility of biliary tract organisms to rifamide.
• To evaluate the clinical efficacy of rifamide in severe acute biliary tract inflammation.
• To assess the prophylactic effect of rifamide in patients undergoing biliary surgery.

Main Methods:

• Minimum inhibitory concentrations (MICs) of rifamide were determined for biliary pathogens.
• Three patients with severe acute biliary tract inflammation were treated with rifamide.
• A randomized controlled trial compared rifamide prophylaxis versus no prophylaxis in 61 patients undergoing biliary surgery.

Main Results:

• Biliary tract organisms were highly sensitive to rifamide at clinically relevant concentrations.
• Rifamide treatment led to rapid clinical improvement in patients with severe biliary inflammation.
• Rifamide prophylaxis reduced the incidence of infected bile and subsequent wound infections in surgical patients.

Conclusions:

• Rifamide demonstrates potent activity against biliary tract pathogens.
• Rifamide is effective in treating acute biliary tract inflammation.
• Rifamide prophylaxis can decrease infectious complications associated with biliary surgery.